Literature DB >> 21818085

A step toward slaying the hydra of second cancers.

Lindsay M Morton, Stephen J Chanock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21818085     DOI: 10.1038/nm.2428

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

1.  Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.

Authors:  Wendy De Roock; Derek J Jonker; Federica Di Nicolantonio; Andrea Sartore-Bianchi; Dongsheng Tu; Salvatore Siena; Simona Lamba; Sabrina Arena; Milo Frattini; Hubert Piessevaux; Eric Van Cutsem; Chris J O'Callaghan; Shirin Khambata-Ford; John R Zalcberg; John Simes; Christos S Karapetis; Alberto Bardelli; Sabine Tejpar
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

Review 2.  Beyond odds ratios--communicating disease risk based on genetic profiles.

Authors:  Peter Kraft; Sholom Wacholder; Marilyn C Cornelis; Frank B Hu; Richard B Hayes; Gilles Thomas; Robert Hoover; David J Hunter; Stephen Chanock
Journal:  Nat Rev Genet       Date:  2009-04       Impact factor: 53.242

3.  Frequent allelic imbalance on chromosome 6 and 17 correlate with radiation-induced neoplastic transformation of human breast epithelial cells.

Authors:  D Roy; G Calaf; T K Hei
Journal:  Carcinogenesis       Date:  2001-10       Impact factor: 4.944

4.  Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma.

Authors:  Timothy Best; Dalin Li; Andrew D Skol; Tomas Kirchhoff; Sarah A Jackson; Yutaka Yasui; Smita Bhatia; Louise C Strong; Susan M Domchek; Katherine L Nathanson; Olufunmilayo I Olopade; R Stephanie Huang; Thomas M Mack; David V Conti; Kenneth Offit; Wendy Cozen; Leslie L Robison; Kenan Onel
Journal:  Nat Med       Date:  2011-07-24       Impact factor: 53.440

5.  Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.

Authors:  Jun J Yang; Cheng Cheng; Wenjian Yang; Deqing Pei; Xueyuan Cao; Yiping Fan; Stanley B Pounds; Geoffrey Neale; Lisa R Treviño; Deborah French; Dario Campana; James R Downing; William E Evans; Ching-Hon Pui; Meenakshi Devidas; W P Bowman; Bruce M Camitta; Cheryl L Willman; Stella M Davies; Michael J Borowitz; William L Carroll; Stephen P Hunger; Mary V Relling
Journal:  JAMA       Date:  2009-01-28       Impact factor: 56.272

6.  Radiation-induced meningiomas: clinical, pathological, cytokinetic, and cytogenetic characteristics.

Authors:  Ossama Al-Mefty; Cahide Topsakal; Svetlana Pravdenkova; Jeffrey R Sawyer; Michael J Harrison
Journal:  J Neurosurg       Date:  2004-06       Impact factor: 5.115

7.  Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.

Authors:  Lois B Travis; Deirdre A Hill; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Tom Wiklund; Charles F Lynch; Mars B Van't Veer; Ingrid Glimelius; Hans Storm; Eero Pukkala; Marilyn Stovall; Rochelle Curtis; John D Boice; Ethel Gilbert
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

Review 8.  Blimp-1 is a tumor suppressor gene in lymphoid malignancies.

Authors:  Akira Hangaishi; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2010-01-05       Impact factor: 2.490

9.  Understanding mechanisms underlying human gene expression variation with RNA sequencing.

Authors:  Joseph K Pickrell; John C Marioni; Athma A Pai; Jacob F Degner; Barbara E Engelhardt; Everlyne Nkadori; Jean-Baptiste Veyrieras; Matthew Stephens; Yoav Gilad; Jonathan K Pritchard
Journal:  Nature       Date:  2010-03-10       Impact factor: 49.962

10.  Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk.

Authors:  Soumya Raychaudhuri; Brian P Thomson; Elaine F Remmers; Stephen Eyre; Anne Hinks; Candace Guiducci; Joseph J Catanese; Gang Xie; Eli A Stahl; Robert Chen; Lars Alfredsson; Christopher I Amos; Kristin G Ardlie; Anne Barton; John Bowes; Noel P Burtt; Monica Chang; Jonathan Coblyn; Karen H Costenbader; Lindsey A Criswell; J Bart A Crusius; Jing Cui; Phillip L De Jager; Bo Ding; Paul Emery; Edward Flynn; Pille Harrison; Lynne J Hocking; Tom W J Huizinga; Daniel L Kastner; Xiayi Ke; Fina A S Kurreeman; Annette T Lee; Xiangdong Liu; Yonghong Li; Paul Martin; Ann W Morgan; Leonid Padyukov; David M Reid; Mark Seielstad; Michael F Seldin; Nancy A Shadick; Sophia Steer; Paul P Tak; Wendy Thomson; Annette H M van der Helm-van Mil; Irene E van der Horst-Bruinsma; Michael E Weinblatt; Anthony G Wilson; Gert Jan Wolbink; Paul Wordsworth; David Altshuler; Elizabeth W Karlson; Rene E M Toes; Niek de Vries; Ann B Begovich; Katherine A Siminovitch; Jane Worthington; Lars Klareskog; Peter K Gregersen; Mark J Daly; Robert M Plenge
Journal:  Nat Genet       Date:  2009-11-08       Impact factor: 38.330

View more
  4 in total

1.  Genetics and genomics of radiotherapy toxicity: towards prediction.

Authors:  Catharine M West; Gillian C Barnett
Journal:  Genome Med       Date:  2011-08-23       Impact factor: 11.117

2.  A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects.

Authors:  Hao Liu; Kari Hemminki; Jan Sundquist; Bernd Holleczek; Alexander Katalinic; Katharina Emrich; Lina Jansen; Hermann Brenner
Journal:  Cancer Med       Date:  2013-08-27       Impact factor: 4.452

3.  Second primary malignancy after radical prostatectomy in a cohort from the Middle East.

Authors:  Mohammed Shahait; Deborah Mukherji; Nadine Hamieh; Samer Nassif; Mark Jabbour; Raja Khauli; Muhammad Bulbul; Wassim Abou Kheir; Albert El Hajj
Journal:  Prostate Int       Date:  2017-09-30

4.  Current knowledge and future research directions in treatment-related second primary malignancies.

Authors:  Lindsay M Morton; Anthony J Swerdlow; Michael Schaapveld; Safaa Ramadan; David C Hodgson; John Radford; Flora E van Leeuwen
Journal:  EJC Suppl       Date:  2014-05-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.